Physician profile
Michael E Eidelman
NPI 1689656654
$422,636.49
in general payments reported to CMS, 2019-2025
12 companies · $66K in 2025
The $66K reported for 2025 was more than what 97% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $8,557 · 2021: $24K · 2022: $61K · 2023: $144K · 2024: $108K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $291K · Travel and Lodging: $21K · Food and Beverage: $6,201 · Education: $26.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $290,550.00 |
| Travel and Lodging | $21,416.68 |
| Food and Beverage | $6,201.18 |
| Education | $26.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $317,806.00 | 2022-2025 | |
| Allergan, INC. | $103,903.90 | 2019-2022 | |
| Merz North America, INC. | $384.15 | 2019-2023 | |
| Galderma Laboratories, L.P. | $153.48 | 2019-2025 | Dysport |
| Almirall LLC | $73.00 | 2019 | |
| Celgene Corporation | $69.48 | 2019 | |
| Djo, LLC | $61.86 | 2023 | Cmf |
| Leo Pharma INC. | $58.62 | 2019-2025 | Anzupgo |
| Sun Pharmaceutical Industries INC. | $54.39 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.11 | 2019 | |
| Incyte Corporation | $23.74 | 2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $13.76 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eidelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.